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Purpose: Aggressive policies for distal bypass and coronary revascularization increase the 
need to identify alternatives to autologous aphenous vein grafts. We examined the 
performance of arm vein as the primary alternative to contralateral saphenous vein when 
the ipsilateral saphenous vein was not available. 
Methods: A total of 250 arm vein grafts were studied retrospectively in 224 patients (143 
men, 81 women, 82.6% with diabetes, mean age 68.3 years) from February 1989 to April 
1994. Intraoperative angioscopy was carried out to observe valve lysis, remove abnor- 
malities, and select optimal vein segments. 
Results: A total of 85 primary, 103 repeat, and 62 graft revision procedures were done for 
limb salvage in 99.2% of the patients. A total of 41 femoropopliteal, 114 femorotibial- 
pedal, 33 popliteodistal, and 62 jump or interposition grafts were constructed. A total of 
199 grafts were single vein, and 51 were composite vein. The source was cephalic vein alone 
in 50.4%, cephalic and basilic vein in 35.6%, and basilic vein only in 14%. The contralateral 
saphenous vein as an alternative conduit was available in 97 (38.8O/o) instances. 
Interventions guided by angioscopy to "upgrade" the graft were necessary in 51.6%. 
Overall early patency (< 30 days) was 94.8% (n = 13 occlusions). The cumulative primary 
patency rate at 1 year was 70.6%, the secondary patency rate was 76.9%, and the limb 
salvage rate was 88.2%. The 3-year patency rate (limb salvage) was 51.9% (92.4%) for 
primary grafts, 56.7% (67.1~ in revision grafts, and 42.4% (79.9%) in repeat grafts. In 
22.7% (22 of 97) the available contralateral saphenous vein was used for distal 
revascularization within the follow-up period. 
Conclusions: Arm veins are an easily accessible autologous conduit of sufficient length to 
reach the midtibial level. Excellent patency rates allow durable limb salvage in otherwise 
difficult circumstances. Vein configuration and splicing do not affect patency rates, 
but vein quality and repeat operations do. Angioscopy is a valuable adjunct to up- 
grade graft quality. The contralateral saphenous hould be saved for subsequent 
contralateral revascularization r coronary artery bypass grafting. (J VAsc SURG 1996; 
23:130-40.) 
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Several approaches exist for infrainguinal revas- 
cularization in the absence of  a suitable ipsilateral 
saphenous vein. Reports in the literature include 
alternative reconstructive methods uch as endarter- 
ectomy of the superficial femoral artery 1or a bypass 
procedure with alternative bypass conduits such as 
prosthetic grafts. 2,3 Although some enthusiasm has 
been expressed about the use of  polytetrafluoroeth- 
ylene 2'4 or biologic grafts such as the glutaraldehyde 
stabilized human umbilical vein grafts, 5 long-term 
results of  prosthetics for tibial reconstructions and 
repeat operations have been poor. 6 Recently prelimi- 
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nary results with cryopreserved human saphenous 
veins have been published, but high failure rate, cost, 
and availability are limiting factors for the use of these 
grafts. 7,8 Autologous vein grafting with alternative 
vein sources has been advocated as a means of revas- 
cularization when adequate saphenous vein is absent. 
However, it is not well established which vein is the 
graft of choice. Reports have been published favoring 
the contralateral saphenous vein and the lesser saphe- 
nous vein, the deep femoral vein, or the arm veins. 9-1s 
It has been observed that secondary bypass 
procedures "might not perform as well as primary 
bypass procedures.14 Therefore in the case of a repeat 
bypass the question can be raised whether to use the 
contralateral saphenous vein as the "best available 
conduit" for a secondary and therefore compromised 
procedure, or to use arm vein, thus preserving the 
contralateral saphenous vein and providing a better 
chance of limb salvage if the contralateral leg requires 
operation. 
Our practice consists largely of patients with 
diabetes who have severe ischemia requiring distal 
tibial bypass for limb salvage. Patients often are 
admitted with failed bypass procedures or previous 
vein harvest for coronary artery bypass grafting 
(CABG). When faced with the need for an alternative 
to ipsilateral saphenous vein, we have chosen to use 
arm vein in spite of the fact that the contralateral 
saphenous vein was available and might be regarded 
as the graft of choice. 16-19 
In this report we describe our experience with this 
policy of using the arm veins as the primary 
alternative autologous graft source with the intent o 
preserve the contralateral saphenous vein in 244 
patients since 1989. The vein configuration, the 
possibilities and results of vein upgrading, and the 
subsequent fate of the preserved contralateral saphe- 
nous vein will be discussed. 
PATIENTS AND ~VIETHODS 
A consecutive series of patients undergoing op- 
eration for infrainguinal bypass for arterial occlusive 
disease with arm vein as the main autologous conduit 
between January 1989 and April 1994 were included 
in this retrospective s ries. All hospital charts, opera- 
tion notes, and intraoperative angioscopy reports 
were reviewed according to a fixed protocol. 
Follow-up data were collected from hospital records, 
and outpatient charts were collected from the indi- 
vidual surgeons. 
The bypass grafts were divided into three groups 
according to indication for operation. Group 1 
(primary grafts) were those patients who had their 
first distal bypass procedure performed on this 
extremity. Group 2 (repeat grafts) were patients who 
had previously undergone an arterial reconstructive 
operation on the same leg and in whom a new bypass 
graft was constructed because of failure of the 
previous graft. Group 3 (revision grafts) were pa- 
tients who had previously undergone a distal arterial 
reconstructive operation on the ipsilateral leg and 
who had recurrent ischemia caused by stenosis or 
short occlusion of the graft or adjacent artery. A new 
graft was constructed with arm vein, and the previous 
bypass was salvaged and remained in circulation as a 
part of the newly constructed graft. 
In addition to indication for operation, the vein 
configuration and orientation of the vein graft, the 
quality of the vein as assessed by angioscopy, the 
frequency and localization of endoluminal disease, 
and the subsequent surgical decisions were noted and 
investigated for their influence on graft patency. 
Long and short segments of arm vein were used 
depending on the type of procedure performed. For 
long grafts three vein configurations were most 
commonly used (Fig. 1). For the long cephalic vein 
graft the forearm and upper arm cephalic vein was 
harvested from the wrist to the junction with the deep 
venous ystem in the deltoid groove (A-C-D). This 
graft was used either in the nonreversed or reversed 
fashion. The upper arm vein loop graft was a 
continuous graft with the upper arm cephalic and 
basilic veins joined through the median cubital vein 
(A-C-B). The configuration and preparation of this 
vein graft was described in detail previously. 2~ Either 
the basilic vein or the cephalic vein was used in a 
nonreversed fashion. For the forearm cephalic vein- 
upper arm basilic vein graft, the forearm cephalic vein 
in continuity with the upper arm basilic vein was 
harvested from the wrist to the junction of the basilic 
vein with the axillary vein (B-C-D). This graft was 
used only in the nonreversed fashion. The forearm 
basilic vein (C-E) was used only when the forearm 
cephalic vein (C-D) and the upper arm cephalic vein 
(A-C) were unusable. 
For interposition grafts or jump grafts short 
segments of vein from the upper arm or the 
mid-forearm to mid upper arm were harvested (Fig. 
1). Vein segments were taken either from the upper 
arm cephalic vein (A-C) or the upper arm ba~ilic vein 
(B-C) and only occasionally from the forearm ce- 
phalic vein (C-D). These vein grafts were either used 
in the reversed or nonreversed fashion. The decision 
to use the vein graft in the reversed or nonreversed 
configuration was solely dependent on the diameter 
of the vein graft at its proximal and distal end to 
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Basilic Vein Upper Arm Forearm 
Fig. 1. "Hidden" upper arm veins can be used most often, because they are inaccessible to
angioaccess. Median cubital vein (C) is included in most graft configurations and therefore 
requires most attention with regard to upgrading. 
provide optimal size matching to the native arteries. 
Veins were regarded to be of suitable diameter if 
>_ 2.5 mm was in the distended state. 
All arm vein grafts were harvested through a 
continuous incision. During harvest he vein was 
gently dilated and flushed alternately with hepa- 
rin/papaverin solution and was stored in a cooled 
balanced salt solution. The vein was maintained inthe 
distended state as described previously. 21
If a single piece of arm vein proved to be of 
insufficient length to construct he bypass, every 
attempt was made to construct an autologous graft 
with additional alternate vein sources uch as rem- 
nants of the ipsilateral greater saphenous vein, 
additional contralatcral rm vein segments, the con- 
tralateral greater saphenous vein, and the ipsilateral 
lesser saphenous vein. 
Valve lysis was performed with a Mills valvulo- 
tome (Pilling Corporation, Fort Washington, Pa.) 
and was observed in all instances with an angioscope. 
Angioscopy was performed after the vein harvest 
and before implantation of the graft as described 
previously 22,23 by an independent angioscopy team 
with angioscopes ranging from an outer diameter 
from 0.8 to 2.2 mm (Olympus Corporation, Lake 
Success, N. Y.). The angioscope was used to assess 
quality of the vein graft and to guide "upgrading" 
when necessary. 19Arm vein conduits were divided 
into four groups based on angioscopic assessment: 
group 1, no abnormalities, group 2, abnormal and 
upgraded by repair, group 3, abnormal and upgraded 
by resection, and group 4, abnormal but not up- 
graded. Upgrading therefore consisted of either 
repair, where an abnormal segment remained but was 
improved by either endoluminal repair (lysis of 
endoluminal strands or removal of adherent throm- 
bus), or external repair (vein patch angioplasty). If a 
segment of vein was deemed unusable either by 
angioscopy or gross inspection and endoluminal 
repair was not possible, the segment was resected. 
Vein segments of inferior quality, in spite of attempts 
to upgrade, were implanted only when no other vein 
of sufficient length was available. 
Exposure of the distal target arteries was per- 
formed in a standard fashion. For repeat procedures 
alternative nonanatomic routes of bypass-positioning 
were frequently used. Subcutaneous graft placement 
was preferred. 
Postoperative graft surveillance was performed by 
office visits every 3 months during the first year and 
every 6 months thereafter. Graft patency was deter- 
mined by clinical examination i most cases including 
the use of a CW-Doppler scanner by the examining 
surgeon. A graft was regarded patent when a palpable 
pulse was present over the graft or the distal artery. 
In a few patients color-flow Doppler studies were 
performed to confirm presence of a patent graft, but 
this was not a standard procedure for graft surveil- 
lance. Primary patcncy was defined as the undis- 
turbed patency without any further interventions. 
Secondary patency was defined as the overall result- 
ing patcncy of the graft after all further interventions 
to maintain the graft in circulation were performed. 
Graft patency, limb salvage, overall patient sur- 
vival, and survival in subgroups was calculated by the 
life table method as recommended by the Ad Hoc 
Committee on Reporting Standards appointed by 
the Society of Vascular Surgery and the North 
American chapter of the International Society of 
Cardiovascular Surgery. 24 Life tables were prepared 
with the method of Kaplan-Meier 2s in accordance 
with graft survival. Life tables were tested for equaliF 
with the log rank test and Wilcoxon's igned rank test 
with the SAS software package (SAS Institute Inc., 
Cary, N. C.) for computation. 
RESULTS 
The clinical details of the 224 patients who 
underwent 250 bypasses with arm vein are listed in 
Table I. The mean age of the 143 men and 81 women 
was 68.3 years, ranging from 36 to 87 years. A total 
of 82.6% had diabetes. Operation was performed for 
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Table I. Characteristics of 224 patients 
undergoing 250 infrainguinal bypass 
procedures with arm vein as primary 
autogenous vein source 
No. 224 
Men/women 143:81 
Age in years (range) 68.3 (36.2-87.6) 
Diabetes (%) 82.6 
No. 250 
Limb salvage (%) 248 (99.2) 
Claudication (%) 2 (0.8) 
Primary procedures (%) 85 (34) 
Repeat procedures (%) 103 (41.2) 
Revision procedures (%) 62 (24.8) 
limb salvage in 99.2% (n = 248) and for claudica- 
tion in 0.5% (n = 2) procedures. Eighty-five (34%) 
were primary bypass procedures, 103 (41.2%) were 
repeat procedures, and 62 (24.8%) were revision 
procedures. 
The anatomy of the 250 grafts is shown in Table 
II. A total of 62% of the grafts were femorodistal 
grafts (155 of 250). A total of 26.5% (41 of 155) of 
the grafts were constructed from the femoral level to 
the popliteal artery, 9 above and 32 below the knee 
joint. A total of 64.5% were femorotibial procedures 
(100 of 155), 6 to the tibioperoneal trunk, 42 to the 
anterior tibial artery, 25 to the posterior tibial artery, 
and 27 to the peroneal artery. A total of 9% (14 of 
155) of the grafts were constructed from the femoral 
to the pedal vessels. The inflow site for the 155 
femoral grafts was the common femoral artery in 
72.3% (112 of 155) of the cases. In another 43 
(27.7%) the grafts originated from the proximal 
superficial femoral artery in 40 (25.8%), the external 
iliac artery in 2 (1.3%), and from the proximal 
profunda femoris artery in 1 (0.6%). A total of 
13.2% (33 of 250) of the grafts originated from the 
popliteal artery~, reaching to the pedal arteries in 27 
and to the tibial arteries in 6. The inflow site was the 
below-knee popliteal artery in 84.8% (28 of 33) and 
the above-knee popliteal artery in 15.2% (5 of 33). In 
the 62 "nonanatomic" revision procedures 45 were 
distal "outflow jump grafts," 8 interposition grafts, 
and 6 proximal "inflow jump grafts." In three cases 
both an inflow and an outflow jump graft were 
inserted simultaneously. 
The indication for the use of the arm vein was 
primarily made on the availability and quality of the 
ipsilateral saphenous vein as shown in Table III. The 
ipsilateral saphenous vein was previously used for 
revascularization procedures in 86% (215 of 250). 
Previous vein harvest for ipsilateral distal bypass was 
performed in 66.9% (144 of 215) and for contralat- 
eral bypass in 0.9% (2 of 215), for coronary bypass 
Table II. Graft anatomy in 250 distal 
bypass procedures with arm veins and early 
( _< 30 days) primary patency 
VeFcgnt 
patent at 
Anatomy No. 30 days 
Femoro-popliteal 41 97.6 
Above knee 9 100 
Below knee 32 96.~) 
Femoro-tibial 100 95.0 
Tiboperoneal trunc 6 100 
Anterior tibial 42 92.9 
Posterior tibial 25 92.0 
Peroneal 27 100 
Femoro-peda! 14 92.9 
Popliteo-distal 33 93.9 
Pedal 27 96.3 
Tibia! 6 83.3 
"Nonanatomic" grafts 62 93.6 
Distal jump graft 45 91.6 
Interposition 8 100 
Proximal jump graft 6 100 
Inflow and outflow jump grafts 3 100 
Total 250 94.8 
Table III. Indication for the use of arm 
veins as an autogenous conduit in 250 grafts 
No. Percent 
Previous ipsilateral distal bypass* 144 57.6 
Previous CABG with ipsilateral saphenous vein 62 24.8 
Previous ipsilateral bypass and CABG* 7 2.8 
Previous contralateral bypass* 2 0.8 
Previous tripping 12 4.8 
Saphenous vein unsuitable 23 9.2 
Total 250 100 
*Referring to the extremity where the saphenous vein was used in 
this particular procedure. 
in 28.8% (62 of 215), and for both in 3.3% (7 of 
215). In 4.8% (12 of 250) of the cases the vein was 
previously removed because of varicose veins, and in 
9.2% (23 of 250) of the cases the saphenous vein was 
explored but turned out to be unsuitable for distal 
bypass during the operation. 
A variety of configurations of the arm veins in 
different orientations was used and are shown in Fig. 
1 and Table IV. A total of 79.6% of the grafts were 
single-piece vein grafts (199 of 250), and 20.4% (51 
of 250) were composite vein grafts. The cephalic vein 
was the most common source of arm vein in 86% 
(215 of 250) and was the only source of arm vein in 
50.4% (126 of 250). The vein was used either in the 
upper arm-forearm configuration in 32.4% (long 
cephalic vein graft, 81 of 250) or as a short graft in 
18% (short cephalic vein graft, 45 of 250). Short 
cephalic vein grafts were taken from the upper arm in 
82.2% (37 of 45) or the forearm in 17.8% (8 of 45). 
A combination of cephalic vein with the upper arm 
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Table IV. Graft composition and configuration i 199 single vein and 51 composite infrainguinal 
arm vein bypass grafts 
Nonreversed Combined Reversed 
No. (%) No. (%) No. (%) Total no. 
Single-segment vein grafts 123 61.8 
Long grafts 
Upper arm-forearm cephalic 70 95.9 
Upper arm loop - - 
Forearm cephalic-upper a m basilic 18 100 
Upper arm-forearm basilic 1 100 
Short grafts 
Cephalic 16 47.1 
Basilic 18 94.7 
Composite vein grafts 37 72.5 
Long grafts 
Upper arm-forearm cephalic 5 62.5 
Upper arm loop - - 
Forearm cephalic-upper a m basilic 11 100 
Upper arm-forearm basilic 3 100 
Short grafts 
Cephalic 8 72.7 
Basilic 10 83.3 
Total 160 64 
Additional graft sources N % 
Ipsilateral greater saphenous 51 43.1 
Contralateral basilic 22 17.7 
Contralateral cephalic 8 15.6 
Lesser saphenous 3 5.9 
Contralateral greater saphenous 1 1.9 
ePTFE 8 15.6 
54 27.1 22 11.1 199 
- - 3 4.1 73 
54 100 - - 54 
. . . .  18 
. . . .  1 
- -- 18 52.9 34 
- - 1 5 .3  19 
6 11.8 8 15.7 51 
- -- 3 37.5 8 
6 100 -- - 6 
. . . .  11 
. . . .  3 
- - 3 27.3 11 
- - 2 16.7 12 
60 22 30 12 250 
ePTFE, Polytetrafluoroethylene. 
basilic vein was chosen in 35.6% (89 of 250). The 
upper arm cephalic vein in combination with the 
upper arm basilic vein ("upper arm loop graft") was 
used in 24% (60 of 250); the forearm cephalic vein 
in continuity with the upper arm basilic vein was used 
in 11.6% (n = 29 of 250). The basilic vein alone was 
used in 14% (35 of 250). In 87.1% (31 of 35) only 
the upper arm segment of the basilic vein was used; 
the forearm basilic vein was used in 12.9% (4 of 35) 
to obtain a longer basilic vein graft. 
A total of 88% (220 of 250) of the grafts required 
valve lysis either full length in 64% (160 of 250) or 
partially in 24% (60 of 250) when used in the 
combined reversed-nonreversed graft configuration. 
A total of 12% (30 of 250) of the grafts were used in 
the reversed configuration. The reversed vein con- 
figuration was used in 3.5% (6 of 174) of the long 
grafts and in 31.6% (24 of 76) of the short vein 
grafts. The selection to use the vein graft in the 
reversed or nonreversed configuration was based only 
on the diameter of the vein, the greater diameter 
being used proximally and the tapered end distally. 
When not enough graft length was obtained with 
the arm vein, additional pieces of vein from other 
sources were used in 84.3% (43 of 51, Table IV). In 
eight instances no other vein source was available, 
and the use of polytetrafluoroethylene was necessary 
(3.2% of all 250 grafts). 
The type of upgrading and the final graft quality 
for each vein configuration is displayed in Table V. A 
total of 50.3% of the single vein grafts (100 of 199) 
and 41.2% (21 of 51) of the composite vein grafts 
were of "good quality." All other grafts required 
"upgrading" either by repair or rejection of a segment 
of vein. A total of 7.5% (15 of 199) grafts of the 
single vein grafts and 3.9% (2 of 51) of the composite 
vein grafts were implanted in spite of being judged to 
be of "inferior quality." No difference was seen in 
either quality or in the need for upgrading between 
the different vein configurations. 
Seven local complications were observed; they 
were attributable to the harvest of the arm veins in 
seven patients (2.8% of all 250 procedures). Three 
patients had pain in the forearm, two had numbness 
in the volar aspect of the forearm, and another two 
had swelling of the forearm and upper arm. Only one 
patient required aggressive pain treatment with an 
axillary block for long-term pain relief. In all instances 
the complications were related to the harvest of the 
upper arm basilic vein. 
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Table V. Vein quality and type of upgrading in 199 single vein and 51 composite infrainguinal 
arm vein bypass grafts as judged with angioscopy 
"Upgraded" 
Good Repair Resection 
No. No. Percent No. Percent No. Percent 
Upgrading incomplete 
No. Percent 
Single-segment vein grafts 199 100 50.3 51 25.6 33 16.6 15 7.5 
Long grafts 
Upper arm-forearm cephalic 73 35 47.9 19 26.0 11 15.1 8 11.0 , 
Upper arm loop 54 29 53.7 15 27.8 7 13.0 3 5.5 
Forearm cephalic-upper a m basilic 18 6 33.3 4 22.2 6 33.3 2 11.1 
Upper arm-forearm basilic 1 100 . . . . . .  
Short grafts 
Cephalic 34 22 64.7 9 26.5 3 8.8 - - 
Basilic 19 7 36.8 4 21.1 6 31.6 2 10.5 
Composite vein grafts 51 21 41.2 13 25.5 15 29.4 2 3.9 
Long grafts 
Upper arm-forearm cephalic 8 2 25.0 4 50.0 2 25.0 - - 
Upper arm loop 6 4 60.6 - - 1 16.7 1 16.7 
Forearm cephalic-upper a m basilic 11 4 36.4 3 27.2 4 36.4 - - 
Upper arm-forearm basilic 3 1 33.3 - - 2 66.7 - - 
Short grafts 
Cephalic 11 5 45.4 2 18.2 4 36.4 - - 
Basilic 12 5 41.7 4 33.3 2 16.7 1 8.7 
Total 250 121 48.4 64 25.6 48 19.2 17 6.8 
Operative mortality ( _< 30 days) was 2.8% (7 of 
250) for all procedures. Primary early (<_ 30 days) 
patency for all grafts is shown in Table II. Overall 
early ( _< 30 days) patency was 94.5%. No statistical 
difference could be demonstrated between the dif- 
ferent anatomic subgroups with regard to early 
patency. 
Follow-up data were obtained after a median 
follow-up of 14.8 months. Patient survival was 
92.7% after 1 year and reached 80.7% (SEM 4.61%) 
after 3 years. No statistically significant difference was 
seen among the three groups (Fig. 2). Primary and 
revised patency are displayed in Fig. 3. At 3 years 
primary patency was 49.5% (SEM 5.97%), and 
revised pater~cy was 52.8% (SEM 6.98%). Overall 
limb salvage was 80.44% after 4 years (SEM 3.9%). 
Grafts inserted for primary revascularization resulted 
in limb salvage of 92.4% (SEM 4.14%) at 3 years 
compared with 79.9% (SEM 4.96%) for repeat 
procedures and 67.1% (SEM 9.97%) for revision 
procedures, as shown in Fig. 4. The difference 
between primary grafts and repeat grafts is statisti- 
cally significant with ap value of 0.04 (log rank test), 
and the difference between primary grafts and 
revision grafts is statistically significant with ap value 
of 0.028 (log rank test) and 0.02 (Wilcoxon's test). 
No difference was seen in graft patency or limb 
salvage with regard to the anatomy of the vein being 
used or the type of procedure being performed. 
Patency of primary grafts was better than that of 
grafts inserted for repeat operation or revision 
operation (Fig. 5). Primary patency at 3 years was 
51.9% (SEM 11.05%) for primary grafts, 42.4% 
(SEM 9.44%) for repeat grafts, and 56.7% (SEM 
8.59%) for revision grafts. The difference between 
primary grafts and revision grafts did not reach 
statistical significance (p = 0.28, log rank test, 
p = 0.26, Wilcoxon's test). The difference between 
primary grafts and repeat grafts was statistically 
significant with a p value of 0.035 (log rank test). 
The importance of graft quality and angioscopi- 
cally guided upgrading is shown in Fig. 6. Good 
quality grafts perform better than "upgraded" vein 
grafts and vein grafts of "inferior" quality. The 
difference is statistically significant with a p value of 
0.04 (log rank test). No difference was noted 
between normal vein grafts and "upgraded" vein 
grafts. No difference could be demonstrated between 
grafts upgraded either by repair or rejection of a 
segment with regard to primary patency. Vein 
splicing did not influence primary graft patency. 
Single vein grafts display a slightly better primary 
patency than composite vein grafts, but the difference 
does not reach statistical difference (log rank, 
p --- 0.158, Wilcoxon, p -- 0.227). 
At the time of operation the contralateral saphe- 
nous vein was available as an alternative autologous 
conduit in 38.8% (97 of 250) of the procedures, as 
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Fig. 2. Life table analysis of patient survival undergoing arm vein grafting. Group 1 (primary 
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Fig. 3. Life table analysis of primary and secondary patency of all 250 arm vein grafts (median 
follow-up, 14.8 months). 
shown in Table VI. In 54% (135 of 250) the vein had 
been used either for previous revascularizations or 
was unavailable because of other reasons in 7.2% (18 
of 250). In 42.4% (106 of 250) the vein was used for 
distal bypass on the same leg and in 8.4% (21 of 250) 
for CABG, and in eight cases the saphenous vein was 
used for previous revascularization f the contralat- 
eral extremity. In 7.2% (18 of 250) the saphenous 
vein was unavailable because of other reasons, in 
3.6% (9 of 250) because of varicose vein stripping, 
and in 2.4% (6 of 250) because of previous major 
amputation, and in 1.2% (3 of 250) the contralateral 
saphenous vein was of unsuitable quality to serve as 
a conduit. 
All 97 available contralateral saphenous veins 
were preserved for possible later use as an arterial 
conduit. During follow-up 22.7% (22 of 97) of these 
veins were used for contralateral limb revasculariza- 
tion, and one was used for both distal bypass and 
CABG. A Kaplan-Meier estimatior~ showing the 
cumulative risk of bypass with the contralateral 
saphenous vein is shown in Fig. 7. The probability for 
saphenous vein use for distal bypass after the first year 
was 16% (SEM 4.71%), 27.8% (SEM 6.93%)'after 
the second year, and 59.1% (SEM 12.08%) after the 
third year. 
DISCUSSION 
Our study shows that arm veins are available as a 
source of autologous conduit in the absence of the 
ipsilateral saphenous vein. Long-term results are 
promising with regard to graft patency and limb 
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salvage. Surgica] ingenuity may be required in certain 
cases to prepare agraft of  sufficient length and quality 
but is possible in nearly 80% of the cases. Angioscopy 
is a valuable adjunct for intraoperative vein quality 
assessment and for guidance of valve lysis. Upgrading 
of vein segments of initially inferior quality is 
necessary in 52% of the cases and results in better 
performance of the vein grafts, because "upgraded" 
vein grafts display patency rates similar to "good 
quality" grafts and yield better patency rates than vein 
grafts of "inferior" quality. Composite grafts do not 
perform as well as single vein grafts, but the 
difference is statistically not significant. Grafts in- 
serted for primary revascularization display better 
patency rates and yield better limb salvage rates than 
revascularization with repeat grafts and graft revi- 
sions. Harvest of the upper extremity veins is safe and 
causes complications in less than 3% and is related to 
the harvest of the deep upper arm basilic vein only. 
The contralateral saphenous vein as an alternative 
option of autologous vein was present in our series in 
only 38.8%. In our primarily diabetic patient popu- 
lation it should be preserved for later use as a distal 
bypass on the contralateral leg or for CABG; in our 
series it was necessary with a probabilit~ of 60% at 3 
years of follow-up. 
Previous studies show absence of the ipsilateral 
saphenous vein in 45% of the patients. 26 Several 
options for construction of a bypass in these circum- 
stances are widely discussed. The main options are 
alternative autologous vein grafting versus the use of 
prosthetic grafts or cryopreserved human vein grafts. 
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Table VI. Availability of contralateral 
saphenous vein as an alternative autogenous 
conduit in 250 infraguinal arm vein 
bypass procedures 
No. Percent 
Greater saphenous vein available 97 38.8 
Previous ipsilateral bypass* 106 42.4 
Previous contralateral bypass* 8 3.2 
Previous CABG 21 8.4 
Previous stripping 9 3.6 
Previous major amputation 6 2.4 
Vein of unsuitable quality 3 1.2 
Total 250 100 
*Referring to the extremity where the saphenous vein was used in 
this particular procedure. 
Prosthetic grafts are readily available, and support 
may exist for their use in certain settings. Promising 
results have been reported for short grafts above the 
knee, but the results are less favorable for tibial 
grafting and repeat procedures. 2'4'6 Autologous vein 
grafting is challenging because of limited vein 
sources, and these rather complex procedures are 
known to be time-consuming, tedious, and may 
require a two-team approach for vein procurement to 
shorten the operating time. 26 The options are the 
contralateral saphenous vein, the lesser saphenous 
veins, or the veins of the arm.  9Hdsds '27  Consider- 
ation must be given to the availability, ease of vein 
harvest, and length and quality of the conduit. Many 
surgeons prefer the use of a saphenous vein because 
it is of  consistent quality, and the procedure can be 
done with regional anesthesia. 
In spite of the initial report by Kakkar 2s in 1969 
demonstrating that the cephalic vein can be used 
successfully as a bypass conduit, only a few reports are 
available dealing with larger series of arm vein 
grafts. 13ds,27,29 Arm veins are fragile and sometimes 
of inconsistent quality, which is associated with poor 
graft performance if not recognized? 9 In addition, 
vein harvest from the arm requires general anesthesia 
and preparation of two distant operating fields. 
Often the entire arm must be explored to find 
enough suitable vein segments to reach the distal 
target artery (Fig. 2). The upper arm veins were used 
for most bypass procedures, because they are less 
frequently injured by previous angioaccess. In 70% 
the cephalic vein and in 49.6% the basilic vein were 
included in the graft (Fig. 2). The forearm veins can 
be used less often, the cephalic vein in 46% and the 
basilic vein in only 1.6%. The single most frequently 
used graft configuration was the upper arm-forearm 
cephalic vein in 32.4%. If the cephalic vein in the 
cubital area and beyond is scarred because of ascend- 
ing thrombosis caused by previous angioaccess, the 
upper arm basilic vein instead will provide additional 
graft length. If  the forearm veins are too narrow, both 
upper arm veins alone can serve as a continuous graft. 
The "loop graft" configuration was used in 24%. This 
graft configuration is possible in most cases "and will 
provide a durable graft in otherwise difficult circum- 
stances. 2~176 No compromise in venous drainage of 
the arm has been observed. The median cubital vein 
is included in most graft configurations, and endolu- 
minal upgrading is often necessary in this vein 
segment. A perforating branch or the forearm basilic 
vein is usually present and should be preserved; it can 
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Fig. 7. Probability of use of preserved contralateral saphenous vein for distal bypass on 
contralateral extremity during follow-up (n = 97). 
be used as a pedicle patch to widen a stenotic median 
cubital vein. Sometimes only resection of this vein 
segment and reanastomosis will provide a graft of 
sufficient quality. 
In spite of the high rate of diabetes (82.6%) in our 
series and the large number of previous arterial 
reconstructions, the veins of the arm were still of 
suitable quality for most cases. Additional graft 
material was necessary in our series in 20.4%. If 
available, remnants of the ipsilateral saphenous vein 
were preferably used, n followed by other arm vein 
segments. Lesser saphenous veins or contralateral 
saphenous veins were used only infrequently (Table 
IV). In 96.2% of the cases a total autologous graft 
could be constructed, and only in 3.8% was artificial 
material necessary. 
Complications caused by the vein harvest from 
the arm were seen infrequently. The continuous 
incisions on the arm healed well, and only a few 
problems after vein harvest were observed. All 
complications were related to the harvest of the upper 
arm basilic vein. Swelling of the forearm and pain in 
the vein harvest site were the most common prob- 
lems. Only one patient required axillary block for 
long-term pain relief. 
The role of intraoperative angioscopy for prepa- 
ration of arm veins is well recognized t8"~9 not only for 
direct observation of valve lysis but also for detection 
and treatment of endoluminal disease, which has 
been associated with graft failure as demonstrated 
previously./9,33's4 A total of 52% of all vein grafts in 
this series required upgrading because of inferior 
quality segments, either by repair in 62.8% (81 of 
129) or by rejection of a vein segment in 37.2% (48 
of 129). No difference in patency was seen between 
vein grafts uccessfully upgraded by either means and 
good quality veins with regard to primary patency. 
Therefore upgrading by endoluminal repair increases 
available graft length but does not compromise graft 
patency. 
Our results corroborate the observation that 
grafts inserted for primary reconstruction perform 
better than those inserted for repeat revasculariza- 
tion) 4 Whereas graft quality in all three groups, 
primary, repeat, and revision grafts, was essentially 
the same, repeat grafts showed a significantly worse 
primary patency rate than primary grafts (Fig. 5). 
Grafts inserted for revision of a failing graft per- 
formed slightly better than repeat grafts but worse 
than primary grafts, but the difference is not statis- 
tically significant. Limb salvage for primary arm vein 
procedures was significantly better than for any 
reoperative procedure as well (Fig. 4). 
It has been suggested that the contralateral 
saphenous vein should be used first as an alternative 
graft to offer the best available vein graft for the 
ischemic extremity. 9 In our series this option was 
present in only 38% of the cases. The lack of 
availability of this source initially prompted the 
search for a reliable alternative vein graft. Out of the 
97 available contralateral saphenous veins', 22 were 
used for distal bypass on the contralateral leg within 
a median follow-up of 14 months. With increasing 
time of follow-up the preserved vein was needed with 
increasing frequency for distal bypass on the con- 
tralateral limb. At 3 years the probability of a distal 
bypass with the preserved vein reached 60% (Fig. 7). 
This finding may well reflect our patient population, 
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which is mainly diabetic and frequently requires 
bilateral procedures. 
The availability of the arm veins even after 
multiple arterial reconstructive procedures and the 
good results with regard to patency and limb salvage 
supports our policy of using the veins of the arm as 
the primary graft of choice in the absence of an 
adequate ipsilateral saphenous vein, especially in 
patients with diabetes mellitus. Preservation of the 
contralateral saphenous vein for contralateral rterial 
reconstruction is a justifiably important consider- 
ation. 
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